FIELD: pharmaceutics.
SUBSTANCE: invention relates to compounds of formula I: 
, as well as to their pharmaceutically acceptable salts.
EFFECT: new compounds have been prepared, as well as pharmaceutical compositions that are useful for binding to CXCR7 and treating mediated diseases such as cancer, inflammatory disease.
28 cl, 1 tbl, 151 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMIDE DERIVATIVES AS GRP119 AGONISTS | 2014 |
|
RU2642429C2 |
| PYRROL[2,3-B]PYRAZINES AS SYK INHIBITORS | 2013 |
|
RU2656853C2 |
| PYRAZOL-4-YL-HETEROCYCLYL-CARBOXAMIDE COMPOUNDS AND METHODS FOR APPLICATION | 2012 |
|
RU2638552C2 |
| COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS | 2016 |
|
RU2717238C2 |
| GCN2 INHIBITORS AND THEIR USE | 2019 |
|
RU2811408C2 |
| CYCLIC AMINE DERIVATIVES AS EP4 RECEPTOR ANTAGONISTS | 2011 |
|
RU2565596C2 |
| ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
| 6-SULFAMOYLQUINOLINE-4-CARBOXYLIC ACIDS, THEIR DERIVATIVES AND COMBINATORY LIBRARY | 2003 |
|
RU2229475C1 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
